[Research on the effect of a new anti-inflammatory thiazole compound, 2-(4-chlorophenyl)-thiazol-4-ylacetate of ethyl, on a model of experimental inflammation with pathogenesis involving the labilization of lysosome membranes].
D000085:Acetates / Q000494:pharmacology; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D007249:Inflammation / Q000188:drug therapy*; D008247:Lysosomes / Q000187:drug effects; D051381:Rats; D013844:Thiazoles / Q000494:pharmacology*
D000085:Acetates; D000894:Anti-Inflammatory Agents, Non-Steroidal; D013844:Thiazoles; C100273:fenclozic acid
Cercetarea influenţei unui nou compus tiazolic antiinflamator, 2-(4-clorfenil)-tiazol-4-il-acetat de etil, asupra unui model de inflamaţie experimentală cu patogenie implicînd labilizarea membranei lizozomilor.